Johnson & Johnson’s Cerebras Systems CBRS Stock Holding History

Johnson & Johnson’s Portfolio CBRS Stock Details CBRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$22.9M	Buy	128,649 +75,063	+140%	+$15.1M	3%	6
2026 Q2	$11.8M	Buy	+53,586	New	+$12.6M	1.48%	9

Other funds holding CBRS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Eclipse Ventures Palo Alto, California $981M AUM 64.81% 1-Year Est. Return

Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Washington University St Louis, Missouri $524M AUM 34.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Johnson & Johnson's CBRS Position: Q3 2026 in Review

Johnson & Johnson increased its Cerebras Systems (CBRS) stake by 140% in Q3 2026, buying an estimated $15.1M and bringing the position to 128,649 shares worth $22.9M. The position accounts for 3% of the portfolio, ranked #6.

Johnson & Johnson first reported a position in CBRS in Q2 2026 and has held it in 2 quarters since. 417 funds tracked by Wall St. Rank hold CBRS as of Q3 2026.

Johnson & Johnson held 128,649 shares of Cerebras Systems worth $22.9M as of Q3 2026.
Johnson & Johnson bought 75,063 Cerebras Systems shares in Q3 2026, an estimated $15.1M.
Cerebras Systems made up 3% of Johnson & Johnson's portfolio in Q3 2026, its #6 holding.
Johnson & Johnson first reported a position in Cerebras Systems in Q2 2026 and has held it in 2 quarters since.
417 funds tracked by Wall St. Rank held Cerebras Systems as of Q3 2026.

Based on Johnson & Johnson's 13F filing for Q3 2026, filed 26 Oct 2026.